Middle East & Africa Dry Eye Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product and Type (Prescription Drugs and OTC Drugs)

List of Tables

The MEA dry eye products market is expected to grow from US$ 212.83 million in 2021 to US$ 262.50 million by 2028. It is estimated to grow at a CAGR of 3.0% from 2021 to 2028.

Rising Incidence of Dry Eye

Incidence and prevalence of dry eye are rising among the population, especially in developed nations. A dry eye is caused by multiple factors, resulting in discomfort, irritation, and visual disturbance. The dry eye incidence is higher among the population in several countries across the region. The MEA region also has increasing prevalence due to chronic health conditions and environmental conditions. According to an article published in 2019 by the Department of Research, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, the incidence of dry eye is high among women. The primary cause of dry eye is the medication for glaucoma. The increasing incidence of dry eye is leading to a rise in the direct cost of treatment. Thus, the increasing incidence of dry eye is expected to drive the dry eye products market across the region.

Market Overview

The MEA dry eye products market includes the consolidated markets for the UAE, Saudi Arabia, South Africa, and the Rest of MEA. Saudi Arabia held the largest share of the MEA dry eye products market in 2021. The country is surrounded by desert, with temperatures reaching more than 50°C in the summers. Thus, dry eye condition is widely seen due to environmental factors. The condition has caused Trachoma endemic disease in some parts of Saudi Arabia. Therefore, the government is implementing campaigns and community-based education programs, which is an influential element for eye health promotion strategies. The strategies are helping in raising awareness and encouraging the community to take steps for maintaining eye health. The action enforces to employ the available eye care services appropriately. For instance, the Ministry of Health (MoH) provides educational messages on eye diseases. This helps educate people about diseases such as glaucoma, amblyopia, diabetic retinopathy, and contact lens.

MEA Dry Eye Products Market Revenue and Forecast to 2028 (US$ Million)

MEA Dry Eye Products Market Segmentation

The MEA dry eye products market is segmented based on product, type, and country.

Based on product, the MEA dry eye products market is segmented into artificial tears, antibiotic drops, hormone drops, and others. The artificial tears segment held the largest market share in 2021. The artificial tears segment is further bifurcated into OTC artificial tears and prescription artificial tears.

Based on type, the MEA dry eye products market is bifurcated into OTC drugs and prescription drugs. The OTC drugs segment held a larger market share in 2021.

Based on country, the MEA dry eye products market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of MEA. Saudi Arabia dominated the market in 2021.

AbbVie Inc; Bausch Health Companies Inc.; Johnson and Johnson Services, Inc.; Novartis AG; OASIS Medical; OCuSOFT Inc.; Prestige Consumer Healthcare Inc.; ROHTO Pharmaceutical Co, Ltd.; Santen Pharmaceutical Co., Ltd.; and URSAPHARM Arzneimittel GmbH are among the leading companies operating in the MEA dry eye products market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MEA dry eye products market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the MEA dry eye products market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the dry eye products market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: TIPRE00016266

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 MEA Dry Eye Products Market - By Product
- 1.3.2 MEA Dry Eye Products Market - By Type
- 1.3.3 MEA Dry Eye Products Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. MEA Dry Eye Products Market - Market Landscape

4.1 Overview
4.2 MEA PEST Analysis
4.3 Expert Opinion

5. MEA Dry Eye Products Market - Key Market Dynamics

5.1 Market Driver
- 5.1.1 Rising Incidences of Dry Eye
- 5.1.2 Growing Older Population
5.2 Market Restraints
- 5.2.1 Side Effects Caused Due to Eye Drops
5.3 Market Opportunities
- 5.3.1 Stem Cell Therapy
5.4 Future Trends
- 5.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
5.5 Impact Analysis of Drivers and Restraints

6. Dry Eye Products Market - MEA Analysis

6.1 MEA Dry Eye Products Market Revenue Forecast and Analysis

7. MEA Dry Eye Products Market Analysis - By Product

7.1 Overview
7.2 MEA Dry Eye Products Market Revenue Share, by Product (2021 and 2028)
7.3 Artificial Tears
- 7.3.1 Overview
- 7.3.2 Artificial Tears: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Over-The-Counter (OTC) Artificial Tears
  - 7.3.3.1 Overview
  - 7.3.3.2 OTC Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Prescription Artificial Tears
  - 7.3.4.1 Overview
  - 7.3.4.2 Prescription Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
7.4 Antibiotics Drops
- 7.4.1 Overview
- 7.4.2 Antibiotic Drops: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Hormone Drops
- 7.5.1 Overview
- 7.5.2 Hormone Drops: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)

8. MEA Dry Eye Products Market Analysis - By Type

8.1 Overview
8.2 MEA Dry Eye Products Market, by Type, 2021 and 2028 (%)
8.3 OTC Drugs
- 8.3.1 Overview
- 8.3.2 OTC Drugs: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Prescription Drugs
- 8.4.1 Overview
- 8.4.2 Prescription Drugs: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)

9. MEA Dry Eye Products Market - Country Analysis

9.1 Overview
- 9.1.1 MEA: Dry Eye Products Market, by Country, 2021 & 2028 (%)
- 9.1.2 Saudi Arabia: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.2.1 Overview
  - 9.1.2.2 Saudi Arabia: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.2.3 Saudi Arabia Dry Eye Products Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.2.3.1 Saudi Arabia: Dry Eye Products Market, by Artificial Tears, 2019-2028 (US$ Million)
  - 9.1.2.4 Saudi Arabia Dry Eye Products Market, Type - Revenue and Forecast to 2028 (US$ Million)
- 9.1.3 UAE: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.3.1 Overview
  - 9.1.3.2 UAE: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.3.3 UAE Dry Eye Products Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.3.3.1 UAE: Dry Eye Products Market, by Artificial Tears, 2019-2028 (US$ Million)
  - 9.1.3.4 UAE Dry Eye Products Market, by Type - Revenue and Forecast to 2028 (US$ Million)
- 9.1.4 South Africa: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.4.1 Overview
  - 9.1.4.2 South Africa: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.4.3 South Africa Dry Eye Products Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.4.3.1 South Africa: Dry Eye Products Market, by Artificial Tears, 2019-2028 (US$ Million)
  - 9.1.4.4 South Africa Dry Eye Products Market, by Type - Revenue and Forecast to 2028 (US$ Million)
- 9.1.5 Rest of MEA: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.5.1 Overview
  - 9.1.5.2 Rest of MEA: Dry Eye Products Market - Revenue and Forecast to 2028 (US$ Million)
  - 9.1.5.3 Rest of MEA Dry Eye Products Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 9.1.5.3.1 Rest of MEA: Dry Eye Products Market, by Artificial Tears, 2019-2028 (US$ Million)
  - 9.1.5.4 Rest of MEA Dry Eye Products Market, by Type - Revenue and Forecast to 2028 (US$ Million)

10. Industry Landscape

10.1 Overview
10.2 Organic Developments
- 10.2.1 Overview
10.3 Inorganic Developments
- 10.3.1 Overview

11. Company Profiles

11.1 Novartis AG
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Santen Pharmaceutical Co., Ltd.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Johnson and Johnson Services, Inc.
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 OASIS Medical
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 URSAPHARM Arzneimittel GmbH
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 ROHTO Pharmaceutical Co, Ltd.
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 OCuSOFT Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Bausch Health Companies Inc.
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 AbbVie Inc.
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Prestige Consumer Healthcare Inc.
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 Glossary of Terms